ConductScience.org, home

Paper39720886

Competitive Antagonism of Xylazine on α7 Nicotinic Acetylcholine Receptors and Reversal by Curcuminoids.

Chen Q and 2 others. ACS Chem Neurosci, 2025. Cited by 5 papers, by iCite.

Cite this record

ConductScience Library. Competitive Antagonism of Xylazine on α7 Nicotinic Acetylcholine Receptors and Reversal by Curcuminoids. Papers, record 39720886. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39720886

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Competitive Antagonism of Xylazine on α7 Nicotinic Acetylcholine Receptors and Reversal by Curcuminoids.
PubMed
Journal
ACS Chem Neurosci
PubMed
Year
2025
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural
PubMed
Citations, by iCite
5
iCite
Relative citation ratio, by iCite
2.1, provisional
iCite
Revised in PubMed
2026-06-01
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Chen QQiang
2Xu YYan
3Tang PPeihttps://orcid.org/0000-0002-2869-2737

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
alpha7 Nicotinic Acetylcholine ReceptorMajor topic
XylazineMajor topic
Adrenergic alpha-2 Receptor AntagonistsMajor topic
Animals
Rats
Xenopus laevis
PC12 Cells
Oocytes
Humans
Acetylcholine

Source PubMed

Download CSV of topics

Grants3

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
R01 DA046939NIDA NIH HHSUnited StatesR01DA046939PubMed and NIHNIH RePORTER
R01 NS122830NINDS NIH HHSUnited StatesR01NS122830PubMed and NIHNIH RePORTER
U54 DK137329NIDDK NIH HHSUnited StatesU54DK137329PubMed and NIHNIH RePORTER

Download CSV of grants

References91

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
134301823Therapeutic Targeting of α7 Nicotinic Acetylcholine Receptors.Pharmacol Rev2021https://conductscience.org/library/papers/34301823PubMed
224672232Efficacy and safety of Curcuma domestica extracts compared with ibuprofen in patients with knee osteoarthritis: a multicenter study.Clin Interv Aging2014https://conductscience.org/library/papers/24672232PubMed
331132111Curcumin Combined with FOLFOX Chemotherapy Is Safe and Tolerable in Patients with Metastatic Colorectal Cancer in a Randomized Phase IIa Trial.J Nutr2019https://conductscience.org/library/papers/31132111PubMed
422743772Fiji: an open-source platform for biological-image analysis.Nat Methods2012https://conductscience.org/library/papers/22743772PubMed
526066335Chronic Supplementation of Curcumin Enhances the Efficacy of Antidepressants in Major Depressive Disorder: A Randomized, Double-Blind, Placebo-Controlled Pilot Study.J Clin Psychopharmacol2015https://conductscience.org/library/papers/26066335PubMed
633478095Natural Polyhydroxy Flavonoids, Curcuminoids, and Synthetic Curcumin Analogs as α7 nAChRs Positive Allosteric Modulators.Int J Mol Sci2021https://conductscience.org/library/papers/33478095PubMed
723425071Curcumin: an orally bioavailable blocker of TNF and other pro-inflammatory biomarkers.Br J Pharmacol2013https://conductscience.org/library/papers/23425071PubMed
827470399Effects of curcumin on serum cytokine concentrations in subjects with metabolic syndrome: A post-hoc analysis of a randomized controlled trial.Biomed Pharmacother2016https://conductscience.org/library/papers/27470399PubMed
931333398Single-Cell Glia and Neuron Gene Expression in the Central Amygdala in Opioid Withdrawal Suggests Inflammation With Correlated Gut Dysbiosis.Front Neurosci2019https://conductscience.org/library/papers/31333398PubMed
1027402494Glial and Neuroimmune Mechanisms as Critical Modulators of Drug Use and Abuse.Neuropsychopharmacology2017https://conductscience.org/library/papers/27402494PubMed
1132162523Natural Products as Sources of New Drugs over the Nearly Four Decades from 01/1981 to 09/2019.J Nat Prod2020https://conductscience.org/library/papers/32162523PubMed
1226648784Role of α7 nicotinic receptor in the immune system and intracellular signaling pathways.Cent Eur J Immunol2015https://conductscience.org/library/papers/26648784PubMed
1333958730Structural basis of human α7 nicotinic acetylcholine receptor activation.Cell Res2021https://conductscience.org/library/papers/33958730PubMed
147545885Clonidine and cirazoline inhibit activation of nicotinic channels in PC-12 cells.Ann N Y Acad Sci1995https://conductscience.org/library/papers/7545885PubMed
1536538321Warning About Xylazine, a Veterinary Sedative Found in Illicit Drugs.JAMA2022https://conductscience.org/library/papers/36538321PubMed
1628092663Neural regulation of immunity: molecular mechanisms and clinical translation.Nat Neurosci2017https://conductscience.org/library/papers/28092663PubMed
1738401117Curcumin - Bioavailability Enhancement by Prodrug Approach and Novel Formulations.Chem Biodivers2024https://conductscience.org/library/papers/38401117PubMed
1831227712α7 nicotinic acetylcholine receptor upregulation by anti-apoptotic Bcl-2 proteins.Nat Commun2019https://conductscience.org/library/papers/31227712PubMed
1925907239Non-neuronal cholinergic system in regulation of immune function with a focus on α7 nAChRs.Int Immunopharmacol2015https://conductscience.org/library/papers/25907239PubMed
2028285851Ivermectin - Old Drug, New Tricks?Trends Parasitol2017https://conductscience.org/library/papers/28285851PubMed

See all 91 referencesDownload CSV of references

Cited by3

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 5 citations.

PMIDTitleJournalYearIn PapersSource
42633410Interpol review of forensic drug chemistry, 2022-2025.Forensic Sci Int Synerg2026https://conductscience.org/library/papers/42633410PubMed
42556608Xylazine reduces methamphetamine-induced hyperlocomotion in rats through κ-opioid and α2-adrenoceptor mechanisms.Neurosci Lett2026https://conductscience.org/library/papers/42556608PubMed
40619654Next-Generation Phospholipid Nanocomplexes for Precision Neurotherapeutics: Harnessing Endogenous Blood-Brain Barrier Transport Mechanisms to Revolutionize the Treatment of Neurodegenerative Diseases.Recent Adv Drug Deliv Formul2026https://conductscience.org/library/papers/40619654PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
ADORA2A135PubTator's text mininghttps://conductscience.org/library/genes/135

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39720886

GET https://conductscience.org/api/papers/v1/39720886/references?page=2